CureVac crashes after crucial COVID-19 vaccine trial disappoints
By Ludwig BurgerJune 17 (Reuters) - CureVac shares fell by as much as 52% on Thursday after the German biotech's COVID-19 vaccine proved only 47% effective...
By Ludwig BurgerJune 17 (Reuters) - CureVac shares fell by as much as 52% on Thursday after the German biotech's COVID-19 vaccine proved only 47% effective...